Skip to main content Skip to navigation
Reducing opioid use via online pain management focus of $2.5M study
September 7, 2017

 By Addy Hatch, WSU Spokane

SPOKANE, Wash. – Marian Wilson, an assistant professor at the WSU College of Nursing, is joining a team of scientists who’ll lead a federally funded, $2.5 million study investigating whether an online pain management program can help patients with chronic pain reduce or eliminate the amount of prescription opioids they take.

Visionary biochemist to receive top WSU alumni award
December 12, 2016

PULLMAN, Wash. – Biochemist James A. Wells, a pioneering engineer of proteins, antibodies and small molecules that target cell sites to thwart disease and enhance drug therapies, will receive the Regents’ Distinguished Alumnus Award at 3:45 p.m. Wednesday, Jan. 25, in the CUB auditorium at Washington State University.

WSU partners to develop new anti-inflammatory drug
October 23, 2015

By Scott Weybright, College of Agricultural, Human & Natural Resource Sciences

David-GangPULLMAN, Wash. – Work on a new anti-inflammatory drug developed from the medicinal/spice plant turmeric recently received funding from a $225,000 grant from the National Institutes of Health National Center for Complementary and Integrative Health (NIH-NCCIH).

WSU eyes collaboration on drugs found in nature
February 7, 2014

By Jane Payumo, Office of International Programs

PhilMech-logo-200PULLMAN, Wash. – The potential healing property of chemicals found in nature was addressed by two Washington State University faculty members recently at a scientific seminar in their home country of the Philippines.

Vet Med offers clinical trial for dogs with cancer
September 28, 2010

 

 

PULLMAN – WSU’s College of Veterinary Medicine is offering a financial incentive to pet owners whose dogs participate in a clinical trial regarding B cell lymphoma, a type of blood cell cancer.

 

Artemisinin is a drug derived from the plant Artemisia annua. It has been traditionally used by Chinese herbalists in the treatment of skin diseases and malaria. In addition to its well-known antimalarial properties, the drug has recently aroused interest as an anticancer drug. 

 

In the laboratory, the drug causes cancer cell death and changes that could sensitize cancers making them more susceptible to common chemotherapy … » More …